Thomas Ulshöfer

867 total citations
33 papers, 601 citations indexed

About

Thomas Ulshöfer is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Thomas Ulshöfer has authored 33 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Oncology. Recurrent topics in Thomas Ulshöfer's work include Sphingolipid Metabolism and Signaling (5 papers), Immune Cell Function and Interaction (3 papers) and Lichen and fungal ecology (2 papers). Thomas Ulshöfer is often cited by papers focused on Sphingolipid Metabolism and Signaling (5 papers), Immune Cell Function and Interaction (3 papers) and Lichen and fungal ecology (2 papers). Thomas Ulshöfer collaborates with scholars based in Germany, United States and Sweden. Thomas Ulshöfer's co-authors include Hermann Ragg, Susanne Schiffmann, Marina Henke, Gerd Geißlinger, Paulus Wohlfart, Irmgard Ihrig‐Biedert, Thomas Herget, Huige Li, Hartmut Kleinert and Thomas Wallerath and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Thomas Ulshöfer

33 papers receiving 591 citations

Peers

Thomas Ulshöfer
Beth A. Strifler United States
Catherine Chang Australia
M.C.M. van Dijk Netherlands
Jennifer L. Carroll United States
Jerry G. Henslee United States
Ellen Herlaar United Kingdom
Beth A. Strifler United States
Thomas Ulshöfer
Citations per year, relative to Thomas Ulshöfer Thomas Ulshöfer (= 1×) peers Beth A. Strifler

Countries citing papers authored by Thomas Ulshöfer

Since Specialization
Citations

This map shows the geographic impact of Thomas Ulshöfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ulshöfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ulshöfer more than expected).

Fields of papers citing papers by Thomas Ulshöfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Ulshöfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ulshöfer. The network helps show where Thomas Ulshöfer may publish in the future.

Co-authorship network of co-authors of Thomas Ulshöfer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Ulshöfer. A scholar is included among the top collaborators of Thomas Ulshöfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Ulshöfer. Thomas Ulshöfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erkoc, Pelin, Susanne Schiffmann, Thomas Ulshöfer, et al.. (2024). Determining the pharmacological potential and biological role of linear pseudoscorpion toxins via functional profiling. iScience. 27(7). 110209–110209. 6 indexed citations
2.
Schiffmann, Susanne, Marina Henke, Thomas Ulshöfer, et al.. (2023). Comparing the Effects of Rocaglates on Energy Metabolism and Immune Modulation on Cells of the Human Immune System. International Journal of Molecular Sciences. 24(6). 5872–5872. 3 indexed citations
3.
Henke, Marina, Thomas Ulshöfer, Michaela Köhm, et al.. (2023). The role of antidrug antibodies in ustekinumab therapy and the impact of methotrexate. Lara D. Veeken. 62(12). 3993–3999. 5 indexed citations
4.
Brachtendorf, Sebastian, Kerstin Birod, Sandra Trautmann, et al.. (2022). T-Cell-Specific CerS4 Depletion Prolonged Inflammation and Enhanced Tumor Burden in the AOM/DSS-Induced CAC Model. International Journal of Molecular Sciences. 23(3). 1866–1866. 18 indexed citations
5.
Schiffmann, Susanne, et al.. (2021). Sodium Bituminosulfonate Used to Treat Rosacea Modulates Generation of Inflammatory Mediators by Primary Human Neutrophils. Journal of Inflammation Research. Volume 14. 2569–2582. 5 indexed citations
6.
Henke, Marina, Thomas Ulshöfer, Garima Singh, et al.. (2020). Unraveling the Pharmacological Potential of Lichen Extracts in the Context of Cancer and Inflammation With a Broad Screening Approach. Frontiers in Pharmacology. 11. 1322–1322. 35 indexed citations
7.
Ulshöfer, Thomas, Marina Henke, Reimar Krieg, et al.. (2020). The immunomodulatory potential of the arylmethylaminosteroid sc1o. Journal of Molecular Medicine. 99(2). 261–272. 3 indexed citations
8.
Gul, Sheraz, Thomas Ulshöfer, Marina Henke, et al.. (2020). In-vitro safety and off-target profile of the anti-parasitic arylmethylaminosteroid 1o. Scientific Reports. 10(1). 7534–7534. 2 indexed citations
9.
Kurz, Jennifer, Thomas Ulshöfer, Marthe-Susanna Wegner, et al.. (2019). Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranes. Scientific Reports. 9(1). 747–747. 1 indexed citations
10.
Feczkó, Tivadar, Albrecht Piiper, Saema Ansar, et al.. (2018). Stimulating brain recovery after stroke using theranostic albumin nanocarriers loaded with nerve growth factor in combination therapy. Journal of Controlled Release. 293. 63–72. 31 indexed citations
11.
Beyer, Susanne, Astrid S. Kahnt, Thomas Ulshöfer, et al.. (2015). Drug Release and Targeting: the Versatility of Polymethacrylate Nanoparticles for Peroral Administration Revealed by Using an Optimized In Vitro-Toolbox. Pharmaceutical Research. 32(12). 3986–3998. 14 indexed citations
13.
Mayer, Christoph, Nerea Ferreirós, Thomas Ulshöfer, et al.. (2015). Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils. Immunology and Cell Biology. 93(9). 825–836. 43 indexed citations
14.
Thomas, Dominique, J. Suo, Thomas Ulshöfer, et al.. (2014). Nano-LC-MS/MS for the quantitation of prostanoids in immune cells. Analytical and Bioanalytical Chemistry. 406(28). 7103–7116. 14 indexed citations
15.
Li, Huige, Thomas Wallerath, Irmgard Ihrig‐Biedert, et al.. (1998). Activation of Protein Kinase Cα and/or ε Enhances Transcription of the Human Endothelial Nitric Oxide Synthase Gene. Molecular Pharmacology. 53(4). 630–637. 133 indexed citations
16.
Ragg, Hermann, et al.. (1990). On the activation of human leuserpin-2, a thrombin inhibitor, by glycosaminoglycans.. Journal of Biological Chemistry. 265(9). 5211–5218. 70 indexed citations
17.
Krämer, Bernhard K., et al.. (1990). Regulation of plasma aldosterone during hemodialysis. PubMed. 13(1). 32–8. 5 indexed citations
18.
Krämer, Bernhard K., et al.. (1990). Regulation of Plasma Aldosterone during Hemodialysis. The International Journal of Artificial Organs. 13(1). 32–38. 4 indexed citations
19.
Krämer, Bernhard K., et al.. (1989). Serum Angiotensin-Converting Enzyme as a Marker of Dialyzer Membrane Biocompatibility?. ˜The œNephron journals/Nephron journals. 53(2). 162–163. 1 indexed citations
20.
Kramer, Benedikt, et al.. (1987). The Renin–Angiotensin–Aldosterone System During Haemodialysis With Acetate or Bicarbonate at Different Dialysate Sodium Concentrations. Nephrology Dialysis Transplantation. 2(6). 531–536. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026